Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB - induced proliferation of vascular smooth muscle cells through blocking PDGF-receptor β phosphorylation

Journal of Pharmacological Sciences

Volumn 116, Issue 2, 2011, Pages 204-213

  Park, Eun Seok ^a   Yoo, Jae Myung ^b   Lim, Yong ^c   Tudev, Munkhtsetseg ^a   Yoo, Hwan Soo ^a   Hong, Jin Tae ^a   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Dong Eui University   (South Korea)

Author keywords

Docetaxel; Platelet derived growth factor receptor (PDGF R ); Proliferation; Vascular smooth muscle cell

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; DOCETAXEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C GAMMA1; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; DRUG STRUCTURE; METABOLIC INHIBITION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 79959347629     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10276FP     Document Type: Article

References (52)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809. (Pubitemid 23132154)
2. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg. 2007;45 Suppl A:A25-A32.
3. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem. 1990;265:10238-10243.
4. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci. 1995;766:416-430.
5. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J Biol Chem. 1994;269:32023-32026.
6. Mulvany MJ. Structure and function of small arteries in hypertension. J Hypertens Suppl. 1990;8:S225-S232.
7. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791-804.
8. Crown J, O'Leary M. The taxanes: an update. Lancet. 2000;355:1176-1178.
9. Ringel I, Horwitz SB. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst. 1991;83:288-291.
10. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277:665-667. (Pubitemid 9114288)
11. Gueritte-Voegelein F, Guenard D, Lavelle F, Le Goff MT, Mangatal L, Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991;34:992-998.
12. Blagosklonny MV, Darzynkiewicz Z, Halicka HD, Pozarowski P, Demidenko ZN, Barry JJ, et al. Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells. Cell Cycle. 2004;3:1050-1056. (Pubitemid 40268664)
13. Kim SJ, Masaki T, Leypoldt JK, Kamerath CD, Mohammad SF, Cheung AK. Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs. J Lab Clin Med. 2004;144:156-162. (Pubitemid 39349037)
14. Chamley JH, Campbell GR, McConnell JD, Groschel-Stewart U. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res. 1977;177:503-522. (Pubitemid 8036319)
15. Park ES, Lim Y, Hong JT, Yoo HS, Lee CK, Pyo MY, et al. Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway. Vascul Pharmacol. 2010;53:61-67.
16. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A. 1990;87:4600-4604. (Pubitemid 20204150)
17. Cui Y, Gutstein WH, Jabr S, Hsieh TC, Wu JM. Control of human vascular smooth muscle cell proliferation by sera derived from 'experimentally stressed' individuals. Oncol Rep. 1998;5:1471-1474.
18. Gutstein WH, Teresi JA, Wu JM, Ramirez M, Salimian F, Cui Y, et al. Increased serum mitogenic activity for arterial smooth muscle cells associated with relaxation and low educational level in human subjects with high but not low hostility traits: implications for atherogenesis. J Psychosom Res. 1999;46:51-61. (Pubitemid 29030510)
19. Uchida K, Sasahara M, Morigami N, Hazama F, Kinoshita M. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis. 1996;124:9-23. (Pubitemid 26188203)
20. Ding H, Wang R, Marcel R, Fisher DZ. Adenovirus-mediated expression of a truncated PDGFbeta receptor inhibits thrombosis and neointima formation in an avian arterial injury model. Thromb Haemost. 2001;86:914-922. (Pubitemid 32834205)
21. Chang Y, Ceacareanu B, Zhuang D, Zhang C, Pu Q, Ceacareanu AC, et al. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Arterioscler Thromb Vasc Biol. 2006;26:501-507.
22. Liu G, Changsirikulchai S, Hudkins KL, Banas MC, Kowalewska J, Yang X, et al. Identification of platelet-derived growth factor D in human chronic allograft nephropathy. Hum Pathol. 2008;39:393-402.
23. Jung F, Haendeler J, Goebel C, Zeiher AM, Dimmeler S. Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphoryla tion in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res. 2000;48:148-157.
24. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645. (Pubitemid 27329445)
25. Blagosklonny MV, Demidenko ZN, Giovino M, Szynal C, Donskoy E, Herrmann RA, et al. Cytostatic activity of paclitaxel in coronary artery smooth muscle cells is mediated through transient mitotic arrest followed by permanent post-mitotic arrest: comparison with cancer cells. Cell Cycle. 2006;5:1574-1579. (Pubitemid 44091979)
26. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:32-330.
27. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-1512. (Pubitemid 29297917)
28. Jirawatnotai S, Aziyu A, Osmundson EC, Moons DS, Zou X, Kineman RD, et al. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem. 2004;279:51100-51106. (Pubitemid 40017852)
29. Martin A, Odajima J, Hunt SL, Dubus P, Ortega S, Malumbres M, et al. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell. 2005;7:591-598. (Pubitemid 40799251)
30. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002;8:1249-1256. (Pubitemid 35373556)
31. Seo JM, Jin YR, Ryu CK, Kim TJ, Han XH, Hong JT, et al. JM91, a newly synthesized indoledione derivative, inhibits rat aortic vascular smooth muscle cells proliferation and cell cycle progression through inhibition of ERK1/2 and Akt activations. Biochem Pharmacol. 2008;75:1331-1340.
32. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 1997;29:334-339. (Pubitemid 27074065)
33. De Donatis A, Comito G, Buricchi F, Vinci MC, Parenti A, Caselli A, et al. Proliferation versus migration in platelet-derived growth factor signaling: the key role of endocytosis. J Biol Chem. 2008;283:19948-19956.
34. Sandirasegarane L, Kester M. Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. Biochem Biophys Res Commun. 2001;283:158-163. (Pubitemid 32912552)
35. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta. 1998;1378:F79-F113. (Pubitemid 28381127)
36. Lai K, Wang H, Lee WS, Jain MK, Lee ME, Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest. 1996;98:1560-1567. (Pubitemid 26327865)
37. Pyles JM, March KL, Franklin M, Mehdi K, Wilensky RL, Adam LP. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res. 1997;81:904-910. (Pubitemid 27514939)
38. Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M, et al. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res. 2001;88:1120-1126. (Pubitemid 34132511)
39. Hughes AD, Clunn GF, Refson J, Demoliou-Mason C. Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen Pharmacol. 1996;27:1079-1089. (Pubitemid 26375419)
40. Hofer MD, Rubin MA. Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer. J Clin Oncol. 2005;23:1332-1333; author reply 1333-1334.
41. Mathew P, Fidler IJ, Logothetis CJ. Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer. Semin Oncol. 2004;31:24-29. (Pubitemid 38879419)
42. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
43. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132. (Pubitemid 21917260)
44. Sirois MG, Simons M, Edelman ER. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation. 1997;95:669-676. (Pubitemid 27063045)
45. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fontanelli A, et al. The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population. Clin Trials Metaanal. 1994;29:31-40. (Pubitemid 24152501)
46. Buchdunger E, O'Reilly T, Wood J. Pharmacology of imatinib (STI571). Eur J Cancer. 2002;38 Suppl 5:S28-S36.
47. Maresta A, Balducelli M, Latini R, Bernardi G, Moccetti T, Sosa C, et al. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. Catheter Cardiovasc Interv. 2005;64:375-382. (Pubitemid 40322053)
48. Toki S, Agatsuma T, Ochiai K, Saitoh Y, Ando K, Nakanishi S, et al. RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptor. J Antibiot (Tokyo). 2001;54:405-414. (Pubitemid 32515102)
49. Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, et al. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation. 1998;97:1960-1969. (Pubitemid 28222191)
50. Yang X, Thomas DP, Zhang X, Culver BW, Alexander BM, Murdoch WJ, et al. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2006;26:85-90. (Pubitemid 43732232)
51. Englesbe MJ, Hawkins SM, Hsieh PC, Daum G, Kenagy RD, Clowes AW. Concomitant blockade of platelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts. J Vasc Surg. 2004;39:440-446. (Pubitemid 38174331)
52. Li L, Blumenthal DK, Masaki T, Terry CM, Cheung AK. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. J Cell Biochem. 2006;99:1553-1563. (Pubitemid 44845715)